247 related articles for article (PubMed ID: 29656869)
1. Comparing Treatment Strategies for Stage I Small-cell lung Cancer.
Paximadis P; Beebe-Dimmer JL; George J; Schwartz AG; Wozniak A; Gadgeel S
Clin Lung Cancer; 2018 Sep; 19(5):e559-e565. PubMed ID: 29656869
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
4. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
[TBL] [Abstract][Full Text] [Related]
5. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
[TBL] [Abstract][Full Text] [Related]
6. Trends in stereotactic body radiation therapy for stage I small cell lung cancer.
Stahl JM; Corso CD; Verma V; Park HS; Nath SK; Husain ZA; Simone CB; Kim AW; Decker RH
Lung Cancer; 2017 Jan; 103():11-16. PubMed ID: 28024690
[TBL] [Abstract][Full Text] [Related]
7. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.
Parashar B; Port J; Arora S; Christos P; Trichter S; Nori D; Wernicke AG
Brachytherapy; 2015; 14(5):648-54. PubMed ID: 25998071
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis.
Verma V; Simone CB; Allen PK; Lin SH
Clin Lung Cancer; 2017 Nov; 18(6):675-681.e1. PubMed ID: 28408183
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection.
Zhong L; Suo J; Wang Y; Han J; Zhou H; Wei H; Zhu J
World J Surg Oncol; 2020 Feb; 18(1):27. PubMed ID: 32013993
[TBL] [Abstract][Full Text] [Related]
10. Definitive treatment patterns and survival in stage II non-small cell lung cancer.
Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS
Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452
[TBL] [Abstract][Full Text] [Related]
11. A SUV
Ye L; Xu F; Shi S; Zeng Z; Jin X; Huang Y; Lu C; Gu J; Ge D; He J
Clin Transl Oncol; 2018 Aug; 20(8):1026-1034. PubMed ID: 29327241
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
[TBL] [Abstract][Full Text] [Related]
13. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma.
Lo H; Abel S; Finley G; Weksler B; Colonias A; Wegner RE
Thorac Cancer; 2020 Feb; 11(2):305-310. PubMed ID: 31860940
[TBL] [Abstract][Full Text] [Related]
15. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
[TBL] [Abstract][Full Text] [Related]
16. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical Resection.
Kastelijn EA; El Sharouni SY; Hofman FN; Van Putte BP; Monninkhof EM; Van Vulpen M; Schramel FM
Anticancer Res; 2015 Oct; 35(10):5607-14. PubMed ID: 26408733
[TBL] [Abstract][Full Text] [Related]
18. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
Koshy M; Malik R; Weichselbaum RR; Sher DJ
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):344-50. PubMed ID: 25636759
[TBL] [Abstract][Full Text] [Related]
19. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
[TBL] [Abstract][Full Text] [Related]
20. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
